| [1] | Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520–532.
|
| [2] | Smith IM, Vickers AB (1960) Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936–1955). Lancet 1: 1318–1322.
|
| [3] | Livermore DM (2000) Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16 Suppl 1S3–10.
|
| [4] | Hiramatsu K, Cui L, Kuroda M, Ito T (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9: 486–493.
|
| [5] | Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, et al. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101: 9786–9791.
|
| [6] | Fuda CC, Fisher JF, Mobashery S (2005) Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci 62: 2617–2633.
|
| [7] | Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM (2001) Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A 98: 8821–8826.
|
| [8] | Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, et al. (2007) Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 104: 9451–9456.
|
| [9] | Bartley J (2002) First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol 23: 480.
|
| [10] | Pinho MG, de Lencastre H, Tomasz A (2001) An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci U S A 98: 10886–10891.
|
| [11] | Fuda C, Suvorov M, Vakulenko SB, Mobashery S (2004) The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem 279: 40802–40806.
|
| [12] | Murakami K, Tomasz A (1989) Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J Bacteriol 171: 874–879.
|
| [13] | de Lencastre H, Tomasz A (1994) Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 38: 2590–2598.
|
| [14] | Georgopapadakou NH (1993) Penicillin-binding proteins and bacterial resistance to beta-lactams. Antimicrob Agents Chemother 37: 2045–2053.
|
| [15] | Suzuki J, Komatsuzawa H, Sugai M, Ohta K, Kozai K, et al. (1997) Effects of various types of Triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillin. FEMS Microbiol Lett 153: 327–331.
|
| [16] | Berger-Bachi B, Strassle A, Gustafson JE, Kayser FH (1992) Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 36: 1367–1373.
|
| [17] | Wu S, deLencastre H, Tomasz A (1996) Sigma-B a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase:molecular cloning and DNA seqeuncing. J. Bacteriol. 178: 6036–6042.
|
| [18] | Maki H, Yamaguchi T, Murakami K (1994) Cloning and characterization of a gene affecting the methicillin resistance level and the autolysis rate in Staphylococcus aureus. J Bacteriol 176: 4993–5000.
|
| [19] | Wu S, de Lencastre H, Sali A, Tomasz A (1996) A phosphoglucomutase-like gene essential for the optimal expression of methicillin resistance in Staphylococcus aureus: molecular cloning and DNA sequencing. Microb Drug Resist 2: 277–286.
|
| [20] | Memmi G, Filipe SR, Pinho MG, Fu Z, Cheung A (2008) Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob Agents Chemother 52: 3955–3966.
|
| [21] | Henze UU, Roos M, Berger-Bachi B (1996) Effects of penicillin-binding protein 4 overproduction in Staphylococcus aureus.. Microb Drug Resist 2: 193–199.
|
| [22] | Jo DS, Montgomery CP, Yin S, Boyle-Vavra S, Daum RS (2011) Improved oxacillin treatment outcomes in experimental skin and lung infection by a methicillin-resistant Staphylococcus aureus isolate with a vraSR operon deletion. Antimicrob Agents Chemother 55: 2818–2823.
|
| [23] | Suzuki T, Campbell J, Swoboda JG, Walker S, Gilmore MS (2011) Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci 52: 3187–3192.
|
| [24] | Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bachi B (1999) The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc Natl Acad Sci U S A 96: 9351–9356.
|
| [25] | Stranden AM, Ehlert K, Labischinski H, Berger-Bachi B (1997) Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 179: 9–16.
|
| [26] | Henze U, Sidow T, Wecke J, Labischinski H, Berger-Bachi B (1993) Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. J Bacteriol 175: 1612–1620.
|
| [27] | McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, et al. (2006) Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin. J Bacteriol 188: 1120–1133.
|
| [28] | Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, et al. (2003) Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149: 2719–2732.
|
| [29] | McCallum N, Spehar G, Bischoff M, Berger-Bachi B (2006) Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. Biochim Biophys Acta 1760: 1475–1481.
|
| [30] | Sobral RG, Jones AE, Des Etages SG, Dougherty TJ, Peitzsch RM, et al. (2007) Extensive and genome-wide changes in the transcription profile of Staphylococcus aureus induced by modulating the transcription of the cell wall synthesis gene murF. J Bacteriol 189: 2376–2391.
|
| [31] | Bernal P, Lemaire S, Pinho MG, Mobashery S, Hinds J, et al. (2010) Insertion of epicatechin gallate into the cytoplasmic membrane of methicillin-resistant Staphylococcus aureus disrupts penicillin-binding protein (PBP) 2a-mediated beta-lactam resistance by delocalizing PBP2. J Biol Chem 285: 24055–24065.
|
| [32] | Komatsuzawa H, Ohta K, Labischinski H, Sugai M, Suginaka H (1999) Characterization of fmtA, a gene that modulates the expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 43: 2121–2125.
|
| [33] | Komatsuzawa H, Sugai M, Ohta K, Fujiwara T, Nakashima S, et al. (1997) Cloning and characterization of the fmt gene which affects the methicillin resistance level and autolysis in the presence of triton X-100 in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 41: 2355–2361.
|
| [34] | Boles BR, Thoendel M, Roth AJ, Horswill AR (2010) Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5: e10146.
|
| [35] | Tu Quoc PH, Genevaux P, Pajunen M, Savilahti H, Georgopoulos C, et al. (2007) Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun 75: 1079–1088.
|
| [36] | Fan X, Liu Y, Smith D, Konermann L, Siu KW, et al. (2007) Diversity of penicillin-binding proteins. Resistance factor FmtA of Staphylococcus aureus. J Biol Chem 282: 35143–35152.
|
| [37] | Piriz Duran S, Kayser FH, Berger-Bachi B (1996) Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett 141: 255–260.
|
| [38] | Deora R, Misra TK (1996) Characterization of the primary sigma factor of Staphylococcus aureus. J Biol Chem 271: 21828–21834.
|
| [39] | Busby S, Ebright RH (1994) Promoter structure, promoter recognition, and transcription activation in prokaryotes. Cell 79: 743–746.
|
| [40] | Siegele DA, Hu JC, Walter WA, Gross CA (1989) Altered promoter recognition by mutant forms of the sigma 70 subunit of Escherichia coli RNA polymerase. J Mol Biol 206: 591–603.
|
| [41] | Waldburger C, Gardella T, Wong R, Susskind MM (1990) Changes in conserved region 2 of Escherichia coli sigma 70 affecting promoter recognition. J Mol Biol 215: 267–276.
|
| [42] | Tatti KM, Shuler MF, Moran CP Jr (1995) Sequence-specific interactions between promoter DNA and the RNA polymerase sigma factor E. J Mol Biol 253: 8–16.
|
| [43] | Chan PF, Foster SJ (1998) Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 180: 6232–6241.
|
| [44] | Cheung AL, Nishina KA, Trotonda MP, Tamber S (2008) The SarA protein family of Staphylococcus aureus. Int J Biochem Cell Biol 40: 355–361.
|
| [45] | Liu Y, Manna AC, Pan CH, Kriksunov IA, Thiel DJ, et al. (2006) Structural and function analyses of the global regulatory protein SarA from Staphylococcus aureus. Proc Natl Acad Sci U S A 103: 2392–2397.
|
| [46] | Schumacher MA, Hurlburt BK, Brennan RG (2001) Crystal structures of SarA, a pleiotropic regulator of virulence genes in S. aureus. Nature 409: 215–219.
|
| [47] | Chien Y, Manna AC, Projan SJ, Cheung AL (1999) SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J Biol Chem 274: 37169–37176.
|
| [48] | Hong M, Fuangthong M, Helmann JD, Brennan RG (2005) Structure of an OhrR-ohrA operator complex reveals the DNA binding mechanism of the MarR family. Mol Cell 20: 131–141.
|
| [49] | Rao L, Karls RK, Betley MJ (1995) In vitro transcription of pathogenesis-related genes by purified RNA polymerase from Staphylococcus aureus. J Bacteriol 177: 2609–2614.
|
| [50] | Belcheva A, Verma V, Korenevsky A, Fridman M, Kumar K, et al. (2012) Roles of DNA sequence and sigma A factor in transcription of the vraSR operon. J Bacteriol 194: 61–71.
|
| [51] | Cheung AL, Nishina K, Manna AC (2008) SarA of Staphylococcus aureus binds to the sarA promoter to regulate gene expression. J Bacteriol 190: 2239–2243.
|
| [52] | Francis KP, Joh D, Bellinger-Kawahara C, Hawkinson MJ, Purchio TF, et al. (2000) Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun 68: 3594–3600.
|
| [53] | Lindsay JA, Foster SJ (1999) Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol Gen Genet 262: 323–331.
|
| [54] | Campbell J, Singh AK, Santa Maria JP Jr, Kim Y, Brown S, et al.. (2011) Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus. ACS Chem Biol 6: , 106–116.
|
| [55] | Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, et al. (2003) Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol 49: 807–821.
|
| [56] | Chien Y, Cheung AL (1998) Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus. J Biol Chem 273: 2645–2652.
|
| [57] | Sterba KM, Mackintosh SG, Blevins JS, Hurlburt BK, Smeltzer MS (2003) Characterization of Staphylococcus aureus SarA binding sites. J Bacteriol 185: 4410–4417.
|
| [58] | Wolz C, Pohlmann-Dietze P, Steinhuber A, Chien YT, Manna A, et al. (2000) Agr-independent regulation of fibronectin-binding protein(s) by the regulatory locus sar in Staphylococcus aureus. Mol Microbiol 36: 230–243.
|
| [59] | Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ (2004) Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 40: 1–9.
|
| [60] | Trotonda MP, Tamber S, Memmi G, Cheung AL (2008) MgrA represses biofilm formation in Staphylococcus aureus. Infect Immun 76: 5645–5654.
|
| [61] | Trotonda MP, Xiong YQ, Memmi G, Bayer AS, Cheung AL (2009) Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J Infect Dis 199: 209–218.
|
| [62] | Lamichhane-Khadka R, Cantore SA, Riordan JT, Delgado A, Norman AE, et al. (2009) sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus. Int J Antimicrob Agents 34: 136–141.
|
| [63] | Manna AC, Ingavale SS, Maloney M, van Wamel W, Cheung AL (2004) Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus. J Bacteriol 186: 5267–5280.
|
| [64] | Ingavale SS, Van Wamel W, Cheung AL (2003) Characterization of RAT, an autolysis regulator in Staphylococcus aureus. Mol Microbiol 48: 1451–1466.
|
| [65] | Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, et al. (2003) SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 48: 1075–1087.
|
| [66] | Bronner S, Monteil H, Prevost G (2004) Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol Rev 28: 183–200.
|
| [67] | Didier JP, Cozzone AJ, Duclos B (2010) Phosphorylation of the virulence regulator SarA modulates its ability to bind DNA in Staphylococcus aureus. FEMS Microbiol Lett 306: 30–36.
|
| [68] | Belcheva A, Verma V, Golemi-Kotra D (2009) DNA-binding activity of the vancomycin resistance associated regulator protein VraR and the role of phosphorylation in transcriptional regulation of the vraSR operon. Biochemistry 48: 5592–5601.
|
| [69] | Sengupta M, Jain V, Wilkinson BJ, Jayaswal RK (2012) Chromatin immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus aureus. Can J Microbiol. 58: , 703–708.
|
